FDA approves Botox to treat chronic migraine
The U.S. Food and Drug Administration today approved Botox injection (onabotulinumtoxinA) to prevent headaches in adult patients with chronic migraine. Chronic migraine is defined as having a history of migraine and experiencing a headache on most days of the month.
Oct 15, 2010
Latest in Home
Mercedes-Benz Debuts Future of Delivery
April 19, 2024
Tennessee Volkswagen Workers to Vote on Union Membership
April 19, 2024